Padmanabh Inds. (526905)
TurnaroundScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹5.9 |
| Market Cap | ₹3.59 Cr |
| P/E Ratio | 73 |
| ROCE | 0.5% |
| ROE | -62.26% |
| Dividend Yield | 0% |
| Profit Growth | 1,000% |
| Debt/Equity | — |
| Sales Growth | 2,471.43% |
| 52-Week Range | ₹5.76 — ₹13 |
| Sector | Chemicals & Petrochemicals |
Strengths
- Latest quarter sales of ₹7 Cr versus market cap of ₹4 Cr indicates high revenue throughput relative to enterprise value
- Sales growth of 2,471% demonstrates significant expansion in business activity, albeit off a low base
- Piotroski F-Score of 7/9 is a rare bright spot, suggesting improving financial health
- Profit growth of 1,000% signals movement toward profitability, though absolute earnings are minuscule
- ROCE is positive at 0.50%, so operations are at least marginally above breakeven at the capital-employed level
Concerns
- ROE is -62.26%, implying depleted or negative equity and severe past value destruction
- Latest quarter net profit is effectively ₹0 Cr, and a P/E of 73 rests on negligible absolute earnings
- Commodity chemicals is a price-taking, no-moat business with weak pricing power and cyclicality
- No dividend, undisclosed promoter holding, and price near the 52-week low (₹5.90 vs ₹13.00 high) add governance and market skepticism
AI Analysis
At Rs 5.90, with a market cap of only Rs 4 crore, this is a microcap commodity chemical maker that grabs attention only because of headline growth: sales up 2,471% and profit up 1,000%. But as Graham would say, look past the neon lights. The latest quarter has sales of Rs 7 crore yet net profit of Rs 0 crore. The P/E of 73 is meaningless when the denominator is a rounding error—at this market cap, total earnings are perhaps Rs 5 lakh, less than a fraction of the price of a Mumbai apartment. Return on equity is disastrous at -62.26%, indicating that shareholders' equity has been depleted, likely into negative territory. Return on capital employed is a feeble 0.50%, hardly a sign of a wonderful business. Commodity chemicals offer no pricing power or moat; anyone with a furnace can compete. The 2,471% sales growth comes off a tiny base and tells me little about durable demand. What I do find mildly encouraging is a Piotroski Score of 7 and a positive profit growth trend; perhaps operations are turning around. But the stock is near its 52-week low, pays no dividend, and promoter holdings are undisclosed—for a 4 crore company, that is a governance red flag. At this price, I am not paying 73 times earnings for a commodity business with negative equity and no demonstrated return. If the turnaround delivers sustained cash profit and the balance sheet is repaired, revisit; today it is a speculation, not an investment.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer